Fundz

Kuria Therapeutics Closes Initial Fundraising Round To Develop Novel Nrf2 Activator

PRIVATESep 08, 2022

Round Type

Funding Round

Little RockBiotechnologyTherapeuticsPharmaceutical

Description

Kuria Therapeutics, a pharmaceutical company developing novel ophthalmic and dermal therapeutics, announced that it has successfully closed its first fundraising round. The offering was met with significant enthusiasm and allowed the company to establish a base of experienced investment partners.

Quick answer

Kuria Therapeutics raised an undisclosed amount in a Funding Round round, dated September 8, 2022. Kuria Therapeutics is based in Little Rock, Arkansas, United States.

How much did Kuria Therapeutics raise?
Kuria Therapeutics raised an undisclosed amount in a Funding Round round on September 8, 2022.
What does Kuria Therapeutics do?
Kuria Therapeutics, Inc. is a US-based pharmaceutical company dedicated to the development of novel therapeutics for ophthalmic and dermal disease.
Where is Kuria Therapeutics based and how big is it?
Kuria Therapeutics is based in Little Rock, Arkansas, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Kuria Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Pharnext raised an undisclosed amount (Debt Financing) on October 3, 2022.
  • Qnovia raised $17M (Series A) on September 28, 2022.
  • Damona Pharmaceuticals raised $5.5M (Seed) on September 28, 2022.
  • Damona Pharmaceuticals raised $5.5M (Seed) on September 26, 2022.
  • CASI Pharmaceuticals raised an undisclosed amount on September 23, 2022.
  • Avenzo Therapeutics raised $31M on September 14, 2022.

Who to call at Kuria Therapeutics, and when

A new round usually means Kuria Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Kuria Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kuria Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kuria Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kuria Therapeutics

Location

Little Rock, Arkansas, United States

About

Kuria Therapeutics, Inc. is a US-based pharmaceutical company dedicated to the development of novel therapeutics for ophthalmic and dermal disease. We are a team of seasoned life science executives and entrepreneurs with decades of experience in building biotechnology companies, running complex multi-national development programs, managing alliances with partners, and building relationships with clinicians, investors, vendors, and patient groups. For more information, visit www.kuriatx.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kuria Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Kuria Therapeutics's next move

See what Strategic adds

Kuria Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.